GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Devyser Diagnostics DVYSR.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

64.90

+0.15%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Devyser Diagnostics annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 250.5mSEK 216.9mSEK 169.3mSEK 126.6mSEK 93.5m
Operating incomeSEK 10.6m−SEK 58.3m−SEK 56.5m−SEK 54.9m−SEK 21.6m
Net income−SEK 8.4m−SEK 61.5m−SEK 53.6m−SEK 46.0m−SEK 20.7m
Free cash flowSEK 6.7m−SEK 123.7m−SEK 101.7m−SEK 66.3m−SEK 25.3m
Total assetsSEK 469.7mSEK 473.8mSEK 510.1mSEK 500.6mSEK 456.9m
Shareholders' equitySEK 354.3mSEK 349.1mSEK 385.1mSEK 431.4mSEK 416.7m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.